Loading...
XHKG
8307
Market cap5mUSD
Jul 06, Last price  
0.11HKD
1D
0.00%
1Q
-20.98%
Jan 2017
-87.16%
IPO
-96.46%
Name

Medicskin Holdings Ltd

Chart & Performance

D1W1MN
XHKG:8307 chart
P/E
47.90
P/S
0.94
EPS
0.00
Div Yield, %
Shrs. gr., 5y
-1.19%
Rev. gr., 5y
2.79%
Revenues
48m
+6.13%
51,607,00065,041,00066,738,00060,073,00062,062,00057,793,00051,449,00048,046,00041,713,00049,147,00045,541,00049,885,00045,108,00047,871,000
Net income
936k
P
14,532,00013,737,0003,328,0002,354,0003,168,0002,533,000-5,480,000-3,237,000953,0003,922,000-3,537,000-3,048,000-3,377,000936,000
CFO
6m
-36.38%
20,532,00022,577,0006,418,0001,841,00016,331,0006,495,0004,212,00014,910,0009,147,0004,294,0003,246,00010,516,0009,132,0005,810,000
Dividend
Jul 05, 20210.025 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.
IPO date
Dec 18, 2014
Employees
28
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT